CARBOGEN AMCIS

About CARBOGEN AMCIS

CARBOGEN AMCIS leverages its world-class chemistry skills to provide seamless drug substance, drug products development and commercialization services for leading pharmaceutical and biopharmaceutical companies. We help customers create a better world by becoming the partner of choice thanks to our innovative solutions. We offer an array of integrated and customized services operating in a fully cGMP-compliant infrastructure, including dedicated Highly Potent API facilities and a clean room for Antibody Drug Conjugates.

  • CH
  • 2015
    On CPHI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Contract Service
Primary activities
API Producer
Clinical Research
Contract Manufacturer
Contract Research Organisation
Contact info
Meet us at

CPHI Frankfurt 2025

Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025

Products from CARBOGEN AMCIS (3)

  • Sterile Drug Product services

    Product Sterile Drug Product services

    CARBOGEN AMCIS offers Sterile Drug Product services, specializing in the formulation, development, and manufacturing of injectable products. With capabilities in lyophilization, sterile filling, and handling highly potent APIs, the company ensures aseptic processing for clinical and commercial supply. ...
  • Drug Substance Services

    Product Drug Substance Services

    CARBOGEN AMCIS provides comprehensive Drug Substance services, offering expertise in process development, scale-up, and manufacturing of active pharmaceutical ingredients (APIs). With state-of-the-art facilities, the company specializes in high-potency compounds, including cytotoxics, and delivers solu...
  • Specialties Services and Products

    Product Specialties Services and Products


    Specialty manufacturing and services provided by CDMOs address the diverse needs of customers in various therapeutic, nutraceutical and dietary supplement areas, as well as in the pharma, personal care, and cosmetics industries.

    With over 70 years of experience, CARBOGEN AMCIS Ve...

CARBOGEN AMCIS Resources (2)

  • News CARBOGEN AMCIS acquires new property at Bubendorf site

    BUBENDORF, Switzerland (24 June, 2021) Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and drug products manufacturing company, announced the acquisition of a new property in Bubendorf.
  • Brochure Company Profile

    Dowload our brochure and learn more about our offers. 
    Drug development to Commercialization services for pharmaceutical and biopharmaceutical industries at all stages of drug development

    Your CDMO from Drug Substance to Drug Product